Similar articles

• Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.

  Million M, Lagier JC, Tissot-Dupont H, Ravaux I, Dhiver C, Tomei C, Cassir N, Delorme L, Cortaredona S, Amrane S, Aubry C, Bendamardji K, Berenger C, Doudier B, Edouard S, Hocquart M, Mailhe M, Porcheto C, Seng P, Triquet C, Gentile S, Jouve E, Giraud-Gatineau A, Chaudet H, Camoin-Jau L, Colson P, Gautret P, Fournier PE, Maille B, Deharo JC, Habert P, Gaubert JY, Jacquier A, Honore S, Guillon-Lorvellec K, Obadia Y, Parola P, Brouqui P, Raoult D. Million M, et al. Rev Cardiovasc Med. 2021 Sep 24;22(3):1063-1072. doi: 10.31083/j.rcm2203116. Rev Cardiovasc Med. 2021. PMID: 34565108
• Risk Factors of Coronavirus Disease 2019-Related Mortality and Optimal Treatment Regimens: A Retrospective Study.

  Wang Y, Yao S, Liu X, Cao Y, Wang Y, Xie M. Wang Y, et al. Med Sci Monit. 2021 Feb 11;27:e926751. doi: 10.12659/MSM.926751. Med Sci Monit. 2021. PMID: 33571171 Free PMC article.
• Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.

  Procter BC, Ross C, Pickard V, Smith E, Hanson C, McCullough PA. Procter BC, et al. Rev Cardiovasc Med. 2020 Dec 30;21(4):611-614. doi: 10.31083/j.rcm.2020.04.260. Rev Cardiovasc Med. 2020. PMID: 33388006
• Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).

  McCullough PA, Alexander PE, Armstrong R, Arvinte C, Bain AF, Bartlett RP, Berkowitz RL, Berry AC, Borody TJ, Brewer JH, Brufsky AM, Clarke T, Derwand R, Eck A, Eck J, Eisner RA, Fareed GC, Farella A, Fonseca SNS, Geyer CE Jr, Gonnering RS, Graves KE, Gross KBV, Hazan S, Held KS, Hight HT, Immanuel S, Jacobs MM, Ladapo JA, Lee LH, Littell J, Lozano I, Mangat HS, Marble B, McKinnon JE, Merritt LD, Orient JM, Oskoui R, Pompan DC, Procter BC, Prodromos C, Rajter JC, Rajter JJ, Ram CVS, Rios SS, Risch HA, Robb MJA, Rutherford M, Scholz M, Singleton MM, Tumlin JA, Tyson BM, Urso RG, Victory K, Vliet EL, Wax CM, Wolkoff AG, Wooll V, Zelenko V. McCullough PA, et al. Rev Cardiovasc Med. 2020 Dec 30;21(4):517-530. doi: 10.31083/j.rcm.2020.04.264. Rev Cardiovasc Med. 2020. PMID: 33387997 Review.
• Antibiotics for the Treatment of COVID-19.

  Crawford-Faucher A. Crawford-Faucher A. Am Fam Physician. 2022 Mar 1;105(3):237-238. Am Fam Physician. 2022. PMID: 35289561 Review. No abstract available.